Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients

Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transplant Direct
Hoofdauteurs: Axelrod, David A., Lentine, Krista L., Balakrishnan, Ramji, Chang, Su-Hsin, Alhamad, Terek, Xiao, Huiling, Kasiske, Bertran L., Bloom, Roy D., Schnitzler, Mark A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2020
Onderwerpen:
Kidney Transplantation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/
https://ncbi.nlm.nih.gov/pubmed/33204825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items